FDA Device Intelligence
HomeACCELERATE DIAGNOSTICS, INC. › Accelerate Pheno™ System

Accelerate Pheno™ System

ACCELERATE DIAGNOSTICS, INC. · Model 10301008 · UDI-DI 00862011000321

PRH
1
510(k) clearances
4
Adverse events
4
Recalls
0
Facilities

Description

The Accelerate Pheno™ system is a fully-integrated in vitro diagnostic system comprised of one to four module(s), a Control PC, Analysis PC(s), touchscreen monitor and Accelerate Pheno system software for use with Accelerate PhenoTest™ kits. It is designed to perform identification (ID) and quantitation of bacterial and yeast cells in less than 90 minutes and antimicrobial susceptibility testing (AST) on average in less than 7 hours directly from patient samples. Identification uses fluorescence in situ hybridization (FISH) and susceptibility testing uses microscopic observation of individual, live, growing bacterial cells in near real time (approximately every 10 minutes) in the presence of antimicrobial agents.

Recalls

DateFirmReason
2022-10-17Accelerate Diagnostics IncDue improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting in false positive identification results for Staphylococcus aureus and
2022-10-17Accelerate Diagnostics IncDue improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting in false positive identification results for Staphylococcus aureus and
2018-03-14Accelerate Diagnostics IncThe kits may produce an elevated rate of false positive calls for the Staphylococcus aureus identification probe (SAU).
2017-03-13Accelerate Diagnostics IncRare isolates of Enterobacteriaceae may generate a susceptible meropenem Minimum Inhibitory Concentration (MIC) using the affected device and a resistant result by broth microdilut

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.